LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device ...

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality ...

AngioDynamics (NASDAQ:ANGO) said that it has received breakthrough device designation from the FDA for its AngioVac System for the non-surgical removal of vegetation from the right heart. The ...

Lush vegetation is great for a gardener, but alarming for a cardiologist. For them, the news that Angiodynamics Inc. received U.S. FDA breakthrough device designation for its Angiovac system to remove ...

CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away ...

*Pro forma results exclude the Dialysis and BioSentry businesses divested in June 2023 and the PICC, Midline and tip location product portfolios divested in February 2024, as well as the discontinued ...

AngioDynamics has announced it will acquire Vortex Medical, according to a news release. Vortex, based in Norwell, Mass., focuses on the development of medical devices for the removal of thrombus from ...